Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 5, 2007, Pages 356-367

  Chen, Shali ^a   Khan, Zia A ^a,b   Karmazyn, Morris ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Diabetic cardiomyopathy; Endothelin; Hypertrophy; MAPK; NHE 1

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BOSENTAN; CARIPORIDE; ENDOTHELIN 1; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; COCULTURE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERTROPHY; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-HYDROGEN ANTIPORTER; UMBILICAL VEINS;

EID: 34447618617     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.689     Document Type: Article

References (48)

1. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25: 543-567.
2. Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?. Diabetes Care 1995; 18: 708-714.
3. Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart. N Engl J Med 1980; 302: 384-388.
4. Nunoda S, Genda A, Sugihara N, et al. Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels 1985; 1: 43-47.
5. Sutherland CG, Fisher BM, Frier BM, et al. Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function. Histopathology 1989; 14: 593-602.
6. Yarom R, Zirkin H, Stammler G, et al. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 1992; 166: 265-270.
7. Khan ZA, Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 2003; 81: 622-634.
8. Chen S, Evans T, Mukherjee K, et al. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol 2000; 32: 1621-1629.
9. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
10. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
11. Mebazaa A, Mayoux E, Maeda K, et al. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol 1993; 265: H1841-H1846.
12. Nishimura T, Yamada H, Kinoshita M, Ochi J. Endothelin expression during rat heart development: an immunohistochemical and in situ hybridization study. Biomed Res 1994; 15: 291-298.
13. Hileeto D, Cukiernik M, Mukherjee S, et al. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev 2002; 18: 386-394.
14. Karmazyn M, Gan XT, Humphreys RA, et al. The myocardial Na(+)-H(+) exchange: structure, regulation and its role in heart disease. Circ Res 1999; 85: 777-786.
15. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985; 17: 1029-1042.
16. Orlowski J, Grinstein S. Na+/H+ exchangers of mammalian cells. J Biol Chem 1997; 272: 22373-22376.
17. Marano G, Vergari A, Catalano L, et al. Na+/H+ exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts. Br J Pharmacol 2004; 141: 526-532.
18. Jandeleit-Dahm K, Hannan KM, Farrelly CA, et al. Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition. Circ Res 2000; 87: 1133-1140.
19. Gan XT, Chakrabarti S, Karmazyn M. Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation. Can J Physiol Pharmacol 2003; 81: 105-113.
20. Dyck JR, Maddaford TG, Pierce GN, et al. Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res 1995; 29: 203-208.
21. Chen S, Mukherjee S, Chakraborty C, et al. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol 2002; 284: C263-C272.
22. Fillinger MF, Sampson LN, Cronenwett JL, et al. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res 1997; 67: 169-178.
23. Khan ZA, Cukiernik M, Gonder JR, et al. Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci 2004; 45: 287-295.
24. Moffat MP, Karmazyn M. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts. J Mol Cell Cardiol 1993; 25: 959-971.
25. Xin X, Khan ZA, Chen S, et al. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 2004; 84: 1451-1459.
26. Pepe GJ, Burch MG, Sibley CP, et al. Expression of the mRNAs and proteins for the Na1/H1 exchangers and their regulatory factors in baboon and human placental syncytiotrophoblast. Endocrinology 2001; 142: 3685-3692.
27. Schreiber E, Matthias P, Muller MM, et al. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
28. Chen S, Khan ZA, Gukiernik M, et al. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol 2003; 284: E1089-E1097.
29. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 2003; 83: 59-115.
30. Rakusan K, Flanagan MF, Geva T, et al. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 38-46.
31. Rakusan K, Moravec J, Hatt PY. Regional capillary supply in the normal and hypertrophied rat heart. Microvasc Res 1980; 20: 319-326.
32. Chen SC, Cheng JJ, Hsieh MH, et al. Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes. Planta Med 2005; 71: 525-529.
33. Kemp TJ, Aggeli IK, Sugden PH, et al. Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2004; 37: 603-606.
34. Siffert W, Dusing R. Na+/H+ exchange in hypertension and in diabetes mellitus: facts and hypotheses. Basic Res Cardiol 1996; 91: 179-190.
35. Le Prigent K, Lagadic-Gossmann D, Feuvray D. Modulation by pH0 and intracellular Ca2+ of Na(+)-H+ exchange in diabetic rat isolated ventricular myocytes. Circ Res 1997; 80: 253-260.
36. Chen S, Apostolova MD, Cherian MG, et al. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest 2000; 80: 1311-1321.
37. Kramer BK, Smith TW, Kelly RA. Endothelin and increased contractility in adult rat heart myocytes. Role of intracellular alkalosis induced by activation of protein kinase C-dependent Na(+)-H(+) exchanger. Circ Res 1991; 68: 269-279.
38. Williams B, Howard RL. Glucose induced changes in Na+/H+ antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 1994; 93: 2623-2631.
39. Tomlinson DR. Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 1999; 42: 1271-1281.
40. Awazu M, Ishikura K, Hida M, et al. Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 1999; 10: 738-745.
41. Toyoda M, Suzuki D, Honma M, et al. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int 2004, 66: 1107-1114.
42. Fujita H, Omori S, Ishikura K, et al. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol 2004; 286: F120-F126.
43. Wold LE, Ren J. Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun 2004; 318: 1066-1071.
44. Haworth RS, McCann G, Snabaitis AK, et al. Stimulation of the plasma membrane Na+/H+ exchanger NHE1 by sustained intracellular acidosis. Evidence for a novel mechanism mediated by the ERK pathway. J Biol Chem 2003; 278: 31676-31684.
45. Abe J, Okuda M, Huang Q, et al. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras.J Biol Chem 2000; 275: 1739-1748.
46. Kovacic-Milivojevic B, Gardner DG. Regulation of the human atrial natriuretic peptide gene in atrial cardiocytes by the transcription factor AP-1. Am J Hypertens 1993; 6: 258-263.
47. Kinugawa K, Shimizu T, Yao A, et al. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 1997; 81: 911-921.
48. Li J, Brasier AR. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the rennin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 1996; 10: 252-264.